BioSpace News Archive

Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Andrew Guggenhime to its board of directors. Mr. Guggenhime is an accomplished biopharmaceutical industry leader with more than 20 years of experience.

Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform , today announced that Elizabeth Radcliffe has joined the company as Chief Financial Officer.

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has completed patient enrollment in the phase 2 PORT study.

Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives, today announced the addition of gene therapy and rare disease expert, Nicole Paulk, Ph.D., to its Scientific Advisory Board (SAB).

89bio, Inc. announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the BofA Securities 2021 Health Care Conference on Thursday, May 13, 2021 at 1:15 PM ET and the RBC Capital Markets 2021 Global Healthcare Conference on Wednesday, May 19, 2021 at 9:45 AM ET.

Sin Hang Lee, MD, director of Milford Molecular Diagnostics Laboratory, announced that his CLIA-certified laboratory has been granted a permit to perform diagnostic testing for SARS-CoV-2 by nested RT-PCR followed by DNA sequencing on nasopharyngeal swab samples and residues of RNA extracts previously tested by RT-qPCR assays.

UnitedHealth Group, through the United Health Foundation, is donating $1 million in response to the growing coronavirus crisis in India, which is experiencing an unprecedented public health emergency with record-breaking surges in COVID-19 cases and deaths.

Alkame Holdings, Inc., announced entering into a contract to supply Aladyn, Inc. with Personal Protection Equipment.

Today, Health Canada authorized the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age.

As a national and international leader in ambulatory percutaneous nephrolithotomy, Chesapeake Urology’s Advanced Kidney Stone Program recently surpassed 1,000 cases of this intricate outpatient surgical procedure for the removal of complex kidney stones, the highest number of such procedures in the country.